Stock Scorecard



Stock Summary for Amarin Corp (AMRN) - $0.50 as of 11/20/2024 7:44:00 PM EST

Total Score

15 out of 30

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for AMRN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AMRN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AMRN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AMRN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AMRN (27 out of 90)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for AMRN

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin ( AMRN ) 11/19/2024 2:35:00 PM
Top 3 Health Care Stocks You'll Regret Missing In Q4 - Amarin Corp ( NASDAQ:AMRN ) 11/19/2024 12:52:00 PM
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction 11/5/2024 6:58:00 PM
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales 11/1/2024 5:42:00 PM
Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus 11/1/2024 2:18:00 PM
Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View 10/31/2024 3:10:00 PM
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates 10/31/2024 1:32:00 PM
Amarin Plc ( AMRN ) Q3 2024 Earnings Call Transcript 10/31/2024 6:00:00 AM
Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook 10/30/2024 2:07:00 PM
Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA ( icosapent ethyl ) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp ( a ) Oxidation Mechanistic Effect of Eicosapentaenoic Acid ( EPA ) to be Presented at the 60th Annual European Association for the Study of Diabetes ( EASD ) Meeting 9/9/2024 11:30:00 AM

Financial Details for AMRN

Company Overview

Ticker AMRN
Company Name Amarin Corp
Country USA
Description Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 0.50
Price 4 Years Ago 4.89
Last Day Price Updated 11/20/2024 7:44:00 PM EST
Last Day Volume 2,045,274
Average Daily Volume 1,058,076
52-Week High 1.37
52-Week Low 0.46
Last Price to 52 Week Low 8.70%

Valuation Measures

Trailing PE N/A
Industry PE 22.60
Sector PE 40.32
5-Year Average PE 5.24
Free Cash Flow Ratio 0.68
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 3.23
Total Cash Per Share 0.74
Book Value Per Share Most Recent Quarter 1.29
Price to Book Ratio 0.38
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.84
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 411,338,000
Market Capitalization 205,669,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.12%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -94.20%
Annual Earnings Growth 44.13%
Reported EPS 12 Trailing Months -0.10
Reported EPS Past Year -0.07
Reported EPS Prior Year -0.14
Net Income Twelve Trailing Months -39,346,000
Net Income Past Year -59,112,000
Net Income Prior Year -105,803,000
Quarterly Revenue Growth YOY -36.00%
5-Year Revenue Growth 6.73%
Operating Margin Twelve Trailing Months -0.60

Balance Sheet

Total Cash Most Recent Quarter 305,688,000
Total Cash Past Year 320,659,000
Total Cash Prior Year 309,361,000
Net Cash Position Most Recent Quarter 305,688,000
Net Cash Position Past Year 320,659,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 552,097,000
Total Stockholder Equity Prior Year 595,333,000
Total Stockholder Equity Most Recent Quarter 531,375,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -18,865,968
Free Cash Flow Per Share Twelve Trailing Months -0.05
Free Cash Flow Past Year 6,371,000
Free Cash Flow Prior Year -180,691,000

Options

Put/Call Ratio 0.12
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.02
MACD Signal -0.01
20-Day Bollinger Lower Band 0.46
20-Day Bollinger Middle Band 0.62
20-Day Bollinger Upper Band 0.78
Beta 1.93
RSI 34.95
50-Day SMA 0.82
150-Day SMA 1.35
200-Day SMA 2.30

System

Modified 11/20/2024 5:25:47 PM EST